Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 543995

Examining survival data.

A J Coldman·J M Elwood
View original source ↗Export metadata ↓

Abstract

This brief review presents a nonmathematical description of the methods used to describe the outcome of patient groups when the time to an event such as death or disease recurrence is of interest. Calculation of the product-limit, actuarial and relative survival curves is described and the underlying principles are explained. Two statistical tests frequently used in comparing survival curves (the generalized Wilcoxon and the log-rank or Mantel test) are described and an example of their use is given.

Explore related subjects

Epidemiologic MethodsHumansMortalityStatistics as TopicJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A J Coldman, J M Elwood. 1979-10-20. Examining survival data.. https://pubmed.ncbi.nlm.nih.gov/543995/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Biologic synergism and parallelism.

In epidemiologic studies of two binary exposure factors, much attention has been given to the concept of synergism of the factors. The leading dictionary of epidemiology offers two definitions of synergism, one of which this author labels statistical and the other biologic. The epidemiologic literature has been largely concerned with statistical synergism, which is typically measured using additive or multiplicative interaction. This paper focuses on biologic synergism, on the related concept of biologic parallelism, and on the question of how much information can be gleaned about population amounts of biologic synergism and parallelism--information which is of vital interest to epidemiologists. A fundamental identity equates the difference between the amounts of biologic synergism and parallelism to the additive interaction. Two biologic models, the multistage model and the no-hit or immunity model, enhance the interpretation of multiplicative interaction as a measure of statistical synergism, but it is pointed out here that, unfortunately, both models incorporate the strong assumption that there is no parallelism. A third model, the single-hit or vulnerability model, makes the even stronger assumption that there is no biologic synergism and consequently that the additive interaction is equal to minus the amount of parallelism. A consequence of this fact is that a link which has been perceived in the literature to exist between the single-hit model and the additive interaction is false.

Epidemiologic Methods↗